Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson's Disease.
作者信息
Liguori Claudio, Pierantozzi Mariangela, Olivola Enrica, Mercuri Nicola B, Stefani Alessandro
机构信息
Neurophysiopathology Unit, Department of Systems Medicine, University of Rome "Tor Vergata" , Rome , Italy.
Department of Systems Medicine, Movement Disorders Centre, Fondazione Policlinico Tor Vergata , Rome , Italy.
出版信息
Front Neurol. 2015 Dec 21;6:261. doi: 10.3389/fneur.2015.00261. eCollection 2015.
Abstract
摘要
相似文献
1
Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson's Disease.述评：早期帕金森病中缝5-羟色胺能功能障碍的临床关联
Front Neurol. 2015 Dec 21;6:261. doi: 10.3389/fneur.2015.00261. eCollection 2015.
2
Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study.帕金森病早期震颤进展：一项临床和神经影像学研究。
Brain. 2018 Mar 1;141(3):811-821. doi: 10.1093/brain/awx376.
3
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.帕金森病A53Tα-突触核蛋白小鼠模型中的5-羟色胺能功能障碍。
J Neurochem. 2015 Nov;135(3):589-97. doi: 10.1111/jnc.13253. Epub 2015 Aug 25.
4
The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.缰核连接多巴胺能和血清素能系统：在帕金森病中的抑郁应用。
Eur J Neurosci. 2012 Sep;36(6):2822-9. doi: 10.1111/j.1460-9568.2012.08200.x. Epub 2012 Jul 9.
5
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease.高血清素能状态决定特发性帕金森病的发病和进展。
Med Hypotheses. 2019 Dec;133:109399. doi: 10.1016/j.mehy.2019.109399. Epub 2019 Sep 14.
6
Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.在帕金森病的BAC α-突触核蛋白转基因大鼠模型中，严重受损的海马神经发生与早期血清素能缺乏有关。
Neurobiol Dis. 2016 Jan;85:206-217. doi: 10.1016/j.nbd.2015.10.021. Epub 2015 Oct 30.
7
Aging and regenerative capacity of the rat serotonergic system. A morphological, neurochemical and behavioral analysis after transplantation of fetal raphe cells.
Ann N Y Acad Sci. 1990;600:384-402; discussion 402-4. doi: 10.1111/j.1749-6632.1990.tb16896.x.
8
Changes in the firing activity of serotonergic neurons in the dorsal raphe nucleus in a rat model of Parkinson's disease.帕金森病大鼠模型中中缝背核5-羟色胺能神经元放电活动的变化
Sheng Li Xue Bao. 2007 Apr 25;59(2):183-9.
9
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.帕金森病和左旋多巴诱导运动障碍中的血清素标志物。
Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.
10
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.在新发帕金森病中，5-羟色胺能神经元退化在淡漠、焦虑和抑郁中起显著作用。
Brain. 2016 Sep;139(Pt 9):2486-502. doi: 10.1093/brain/aww162. Epub 2016 Aug 17.
引用本文的文献
1
Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases.大脑衰老和神经退行性疾病的进化和基因组观点。
Prog Brain Res. 2023;275:165-215. doi: 10.1016/bs.pbr.2022.10.004. Epub 2023 Feb 3.
2
Commentary: Evaluation of Models of Parkinson's Disease.评论：帕金森病模型的评估
Front Neurosci. 2016 Jun 21;10:283. doi: 10.3389/fnins.2016.00283. eCollection 2016.
本文引用的文献
1
Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.早发性帕金森病中缝核 5-羟色胺能功能障碍的临床相关性。
Brain. 2015 Oct;138(Pt 10):2964-73. doi: 10.1093/brain/awv215. Epub 2015 Jul 23.
2
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.帕金森病A53Tα-突触核蛋白小鼠模型中的5-羟色胺能功能障碍。
J Neurochem. 2015 Nov;135(3):589-97. doi: 10.1111/jnc.13253. Epub 2015 Aug 25.
3
Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.帕金森病患者血浆血清素和5-羟吲哚乙酸水平降低与非运动症状有关。
Parkinsonism Relat Disord. 2015 Aug;21(8):882-7. doi: 10.1016/j.parkreldis.2015.05.016. Epub 2015 May 27.
4
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart.帕金森病患者脑脊液中5-羟色胺受损，但无明显临床对应表现。
PLoS One. 2014 Jul 18;9(7):e101763. doi: 10.1371/journal.pone.0101763. eCollection 2014.
5
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study.帕金森病中 5-羟色胺能功能障碍的分期：一项活体 11C-DASB PET 研究。
Neurobiol Dis. 2010 Oct;40(1):216-21. doi: 10.1016/j.nbd.2010.05.028. Epub 2010 May 31.
6
Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.非抑郁帕金森病患者的脑血清素转运体结合情况
Eur J Neurol. 2007 May;14(5):523-8. doi: 10.1111/j.1468-1331.2007.01727.x.
7
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study.帕金森病中的震颤与血清素能功能障碍：一项11C-WAY 100635正电子发射断层扫描研究
Neurology. 2003 Feb 25;60(4):601-5. doi: 10.1212/01.wnl.0000031424.51127.2b.
8
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.[11C-甲基]间羟基麻黄碱正电子发射断层扫描在帕金森病和多系统萎缩中的应用
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):127-31. doi: 10.1007/s00259-002-1019-7. Epub 2002 Nov 9.
9
Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.多巴胺、5-羟色胺和去甲肾上腺素转运体基因多态性及其与健康志愿者脑脊液中单胺代谢物浓度的关系。
Psychiatry Res. 1998 Jun 2;79(1):1-9. doi: 10.1016/s0165-1781(98)00027-4.
10
Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.同时从人脑脊液和大脑中获取的胺能代谢产物之间的相关性。
Life Sci. 1985 Oct 7;37(14):1279-86. doi: 10.1016/0024-3205(85)90242-5.
Zotero 插件